Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,183) with videos related to
Page
of 119
Sort By:
Revista De Gastroenterologia De Mexico (English)
|
December 6, 2021
Approach to the patient with cholestasis and jaundice syndrome. Joint AMH, AMG, and AMEG scientific position statement
R Contreras-Omaña, J A Velarde-Ruiz Velasco, G E Castro-Narro, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 1, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p
Maider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
Experimental Hematology & Oncology
|
April 30, 2025
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival
Jennifer J Gile, Patrizia Mondello, Zixing Wang, et al.
The New England Journal of Medicine
|
December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
BMJ Open
|
April 15, 2018
Study protocol to assess the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units: a cluster-randomised, crossover trial (The ICU Visits Study)
Regis Goulart Rosa, Maicon Falavigna, Caroline Cabral Robinson, et al.
JCO Precision Oncology
|
May 29, 2024
Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology
Carolina Sgarioni Camargo Vince, Maria Sol Brassesco, Bruna Minniti Mançano, et al.
Movement Disorders Clinical Practice
|
March 23, 2023
Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil
Pedro Renato de Paula Brandão, Danilo Assis Pereira, Talyta Cortez Grippe, et al.
Hepatology (Baltimore, Md.)
|
August 4, 2023
A global action agenda for turning the tide on fatty liver disease
Jeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Page
of 119
Search research articles
Search
Showing results (1101-1110 of 1,183) with videos related to
Sort By:
Page
of 119
Revista De Gastroenterologia De Mexico (English)
|
December 6, 2021
Approach to the patient with cholestasis and jaundice syndrome. Joint AMH, AMG, and AMEG scientific position statement
R Contreras-Omaña, J A Velarde-Ruiz Velasco, G E Castro-Narro, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 1, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p
Maider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
Experimental Hematology & Oncology
|
April 30, 2025
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival
Jennifer J Gile, Patrizia Mondello, Zixing Wang, et al.
The New England Journal of Medicine
|
December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
BMJ Open
|
April 15, 2018
Study protocol to assess the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units: a cluster-randomised, crossover trial (The ICU Visits Study)
Regis Goulart Rosa, Maicon Falavigna, Caroline Cabral Robinson, et al.
JCO Precision Oncology
|
May 29, 2024
Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology
Carolina Sgarioni Camargo Vince, Maria Sol Brassesco, Bruna Minniti Mançano, et al.
Movement Disorders Clinical Practice
|
March 23, 2023
Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil
Pedro Renato de Paula Brandão, Danilo Assis Pereira, Talyta Cortez Grippe, et al.
Hepatology (Baltimore, Md.)
|
August 4, 2023
A global action agenda for turning the tide on fatty liver disease
Jeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Page
of 119